Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Prospective, multicenter, double-blind, phase II, randomized, dose-response study in 5 parallel groups (dose-range).

Phase 2

Bioprojet